DR. PADMAJA V MALLIDI M.D.
Prescription History 1629044821
Internal Medicine - Hematology & Oncology in Roanoke, VA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. PADMAJA V MALLIDI M.D., an active Hematology & Oncology specialist practicing in Roanoke, VA. Our medical registry currently tracks 33 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,095 documented patient claims. Among these therapy options, the most frequently utilized medication is Eliquis, which accounts for 120 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other VA PrescribersVs. VA Avg |
|---|---|---|---|
| EliquisApixaban | 120 | $899.48 | ▲ More than typical |
About Eliquis: Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. Show more ▾ With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood. An antithrombotic agent. In 2024, this provider wrote 120 Medicare prescriptions for Eliquis, about 1.4 times the volume of the typical Virginia prescriber of this medication (84.8). Medicare paid an average of $899.48 per fill, versus $886.94 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 190 30-Day Fills standardized to 30-day supplies 5,700 Days of Medication total across all patients in 2024 | |||
| Anastrozole | 107 | $14.76▼ below VA avg | ▲ More than typical |
About Anastrozole: Anastrozole is used to treat breast cancer in women after menopause. Show more ▾ Some breast cancers are made to grow faster by a natural hormone called estrogen. Anastrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor. It is used in the treatment of ESTROGEN NUCLEAR RECEPTOR-positive breast cancer in postmenopausal women. In 2024, this provider wrote 107 Medicare prescriptions for Anastrozole, about 1.7 times the volume of the typical Virginia prescriber of this medication (64.6). Medicare paid an average of $14.76 per fill, versus $18.01 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 268 30-Day Fills standardized to 30-day supplies 8,040 Days of Medication total across all patients in 2024 | |||
| Levothyroxine Sodium | 84 | $5.98▼ below VA avg | ▼ Less than typical |
About Levothyroxine Sodium: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾ It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. In 2024, this provider wrote 84 Medicare prescriptions for Levothyroxine Sodium, about 63% of the volume of the typical Virginia prescriber of this medication (133). Medicare paid an average of $5.98 per fill, versus $10.42 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 152.3 30-Day Fills standardized to 30-day supplies 4,570 Days of Medication total across all patients in 2024 | |||
| Letrozole | 69 | $21.07▼ below VA avg | ≈ Typical |
About Letrozole: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Letrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women. In 2024, this provider wrote 69 Medicare prescriptions for Letrozole, about 1.2 times the volume of the typical Virginia prescriber of this medication (59.4). Medicare paid an average of $21.07 per fill, versus $24.05 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 159.3 30-Day Fills standardized to 30-day supplies 4,780 Days of Medication total across all patients in 2024 | |||
| Potassium Chloride | 55 | $8.76▼ below VA avg | ≈ Typical |
About Potassium Chloride: This medication is a mineral supplement used to treat or prevent low amounts of potassium in the blood. Show more ▾ A normal level of potassium in the blood is important. Potassium helps your cells, kidneys, heart, muscles, and nerves work properly. Most people get enough potassium by eating a well-balanced diet. Some conditions that can lower your body's potassium level include severe prolonged diarrhea and vomiting, hormone problems such as hyperaldosteronism, or treatment with "water pills"/diuretics. A white crystal or crystalline powder used in BUFFERS; FERTILIZERS; and EXPLOSIVES. It can be used to replenish ELECTROLYTES and restore WATER-ELECTROLYTE BALANCE in treating HYPOKALEMIA. In 2024, this provider wrote 55 Medicare prescriptions for Potassium Chloride, about the same volume as the typical Virginia prescriber of this medication (55.7). Medicare paid an average of $8.76 per fill, versus $20.16 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 64.3 30-Day Fills standardized to 30-day supplies 1,415 Days of Medication total across all patients in 2024 | |||
| Duloxetine Hcl | 52 | $11.71▼ below VA avg | ≈ Typical |
About Duloxetine Hcl: This medication is used to treat certain mental/mood disorders (such as depression, anxiety). Show more ▾ It is also used to help relieve nerve pain (peripheral neuropathy) in people with diabetes or ongoing pain due to medical conditions such as arthritis, chronic back pain, or fibromyalgia (a condition that causes widespread pain). Duloxetine belongs to a class of drugs known as serotonin-norepinephrine reuptake inhibitors (SNRIs). It works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain. A thiophene derivative and selective NEUROTRANSMITTER UPTAKE INHIBITOR for SEROTONIN and NORADRENALINE (SNRI). It is an ANTIDEPRESSIVE AGENT and ANXIOLYTIC, and is also used for the treatment of pain in patients with DIABETES MELLITUS and FIBROMYALGIA. In 2024, this provider wrote 52 Medicare prescriptions for Duloxetine Hcl, about the same volume as the typical Virginia prescriber of this medication (50.6). Medicare paid an average of $11.71 per fill, versus $23.61 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 76 30-Day Fills standardized to 30-day supplies 2,280 Days of Medication total across all patients in 2024 | |||
| Prednisone | 45 | $2.26▼ below VA avg | ≈ Typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2024, this provider wrote 45 Medicare prescriptions for Prednisone, about the same volume as the typical Virginia prescriber of this medication (48.8). Medicare paid an average of $2.26 per fill, versus $4.45 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 63 30-Day Fills standardized to 30-day supplies 1,669 Days of Medication total across all patients in 2024 | |||
| BrukinsaZanubrutinib | 44 | $13,438.13▼ below VA avg | ▲ More than typical |
About Brukinsa: This medication is used to treat certain cancers (mantle cell lymphoma, marginal zone lymphoma, Waldenstrom's macroglobulinemia, chronic lymphocytic leukemia, small lymphocytic lymphoma, follicular lymphoma). Show more ▾ Zanubrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. A Bruton tyrosine kinase (BTK) inhibitor for treatment of Waldenstrom macroglobulinemia. In 2024, this provider wrote 44 Medicare prescriptions for Brukinsa, about 1.6 times the volume of the typical Virginia prescriber of this medication (26.7). Medicare paid an average of $13,438.13 per fill, versus $13,540.21 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 44 30-Day Fills standardized to 30-day supplies 1,320 Days of Medication total across all patients in 2024 | |||
| Ondansetron OdtOndansetron | 41 | $29.73 | ▲ More than typical |
About Ondansetron Odt: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. Ondansetron works by blocking one of the body's natural substances (serotonin) that causes vomiting. A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. In 2024, this provider wrote 41 Medicare prescriptions for Ondansetron Odt, about 1.6 times the volume of the typical Virginia prescriber of this medication (26.1). Medicare paid an average of $29.73 per fill, versus $14.86 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 41 30-Day Fills standardized to 30-day supplies 699 Days of Medication total across all patients in 2024 | |||
| Lenalidomide | 38 | $14,002.25 | ≈ Typical |
About Lenalidomide: Lenalidomide is used to treat various types of cancers. Show more ▾ It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. In 2024, this provider wrote 38 Medicare prescriptions for Lenalidomide, about the same volume as the typical Virginia prescriber of this medication (37.5). Medicare paid an average of $14,002.25 per fill, versus $13,482.61 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 38 30-Day Fills standardized to 30-day supplies 1,064 Days of Medication total across all patients in 2024 | |||
| Acyclovir | 38 | $11.52▼ below VA avg | ▲ More than typical |
About Acyclovir: Acyclovir is used to treat infections caused by certain types of viruses. Show more ▾ It treats cold sores around the mouth (caused by herpes simplex), shingles (caused by herpes zoster), and chickenpox. This medication is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, acyclovir is used to help reduce the number of future episodes. Acyclovir is an antiviral drug. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Acyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. In addition, in people with a weakened immune system, acyclovir can decrease the risk of the virus spreading to other parts of the body and causing serious infections. A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. In 2024, this provider wrote 38 Medicare prescriptions for Acyclovir, about 1.5 times the volume of the typical Virginia prescriber of this medication (24.7). Medicare paid an average of $11.52 per fill, versus $18.06 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 56 30-Day Fills standardized to 30-day supplies 1,537 Days of Medication total across all patients in 2024 | |||
| Hydroxyurea | 38 | $32.44 | ≈ Typical |
About Hydroxyurea: This medication is used by people with sickle cell anemia to reduce the number of painful crises caused by the disease and to reduce the need for blood transfusions. Show more ▾ Some brands are also used to treat certain types of cancer (such as chronic myelogenous leukemia, squamous cell carcinomas). An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. In 2024, this provider wrote 38 Medicare prescriptions for Hydroxyurea, about the same volume as the typical Virginia prescriber of this medication (33.4). Medicare paid an average of $32.44 per fill, versus $21.41 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 100.1 30-Day Fills standardized to 30-day supplies 3,002 Days of Medication total across all patients in 2024 | |||
| Abiraterone Acetate | 34 | $2,938.71 | ≈ Typical |
About Abiraterone Acetate: This medication is used to treat prostate cancer. Show more ▾ Abiraterone belongs to a class of drugs known as anti-androgens (anti-testosterone). Testosterone, a natural hormone, helps prostate cancer to grow and spread. Abiraterone works by blocking the production of testosterone, thereby slowing the growth and spread of prostate cancer. This medication should not be given to women or children. An androstene derivative that inhibits STEROID 17-ALPHA-HYDROXYLASE and is used as an ANTINEOPLASTIC AGENT in the treatment of metastatic castration-resistant PROSTATE CANCER. In 2024, this provider wrote 34 Medicare prescriptions for Abiraterone Acetate, about 75% of the volume of the typical Virginia prescriber of this medication (45.2). Medicare paid an average of $2,938.71 per fill, versus $1,704.07 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 34 30-Day Fills standardized to 30-day supplies 1,020 Days of Medication total across all patients in 2024 | |||
| Olanzapine | 30 | $9.50▼ below VA avg | ▼ Less than typical |
About Olanzapine: This medication is used to treat certain mental/mood disorders (such as schizophrenia, bipolar disorder). Show more ▾ It may also be used in combination with other medication to treat depression. Olanzapine belongs to a class of drugs known as atypical antipsychotics. It works by helping to restore the balance of certain natural substances in the brain. Talk to the doctor about the risks and benefits of treatment (especially when used by teenagers). See also Precautions section. A benzodiazepine derivative that binds SEROTONIN RECEPTORS; MUSCARINIC RECEPTORS; HISTAMINE H1 RECEPTORS; ADRENERGIC ALPHA-1 RECEPTORS; and DOPAMINE RECEPTORS. It is an antipsychotic agent used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER; and MAJOR DEPRESSIVE DISORDER; it may also reduce nausea and vomiting in patients undergoing chemotherapy. In 2024, this provider wrote 30 Medicare prescriptions for Olanzapine, about 70% of the volume of the typical Virginia prescriber of this medication (42.6). Medicare paid an average of $9.50 per fill, versus $32.60 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 36 30-Day Fills standardized to 30-day supplies 1,066 Days of Medication total across all patients in 2024 | |||
| Alendronate Sodium | 26 | $3.49▼ below VA avg | ▼ Less than typical |
About Alendronate Sodium: Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. Show more ▾ Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases as you age, after menopause, or if you are taking corticosteroid medications (such as prednisone) for a long time. This medication works by slowing bone loss. This effect helps maintain strong bones and reduce the risk of broken bones (fractures). Alendronate belongs to a class of drugs called bisphosphonates. A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis. In 2024, this provider wrote 26 Medicare prescriptions for Alendronate Sodium, about 63% of the volume of the typical Virginia prescriber of this medication (41.3). Medicare paid an average of $3.49 per fill, versus $7.88 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 65.5 30-Day Fills standardized to 30-day supplies 1,942 Days of Medication total across all patients in 2024 | |||
| TafinlarDabrafenib Mesylate | 25 | $14,281.93 | ▲ More than typical |
About Tafinlar: Dabrafenib is used to treat various cancers (such as skin, thyroid, lung, solid tumors, brain). Show more ▾ It belongs to a class of drugs known as kinase inhibitors. Dabrafenib works by slowing or stopping the growth of cancer cells. An antineoplastic agent that inhibits BRAF kinase. In 2024, this provider wrote 25 Medicare prescriptions for Tafinlar, about 1.8 times the volume of the typical Virginia prescriber of this medication (13.6). Medicare paid an average of $14,281.93 per fill, versus $13,616.23 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 25 30-Day Fills standardized to 30-day supplies 750 Days of Medication total across all patients in 2024 | |||
| MekinistTrametinib Dimethyl Sulfoxide | 24 | $15,494.38 | ▲ More than typical |
About Mekinist: Trametinib is used to treat various cancers (such as skin, thyroid, lung, solid tumors, brain). Show more ▾ It belongs to a class of drugs known as kinase inhibitors. Trametinib works by slowing or stopping the growth of cancer cells. In 2024, this provider wrote 24 Medicare prescriptions for Mekinist, about 1.8 times the volume of the typical Virginia prescriber of this medication (13.5). Medicare paid an average of $15,494.38 per fill, versus $14,448.22 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 24 30-Day Fills standardized to 30-day supplies 720 Days of Medication total across all patients in 2024 | |||
| Dexamethasone | 22 | $23.99 | ▼ Less than typical |
About Dexamethasone: Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. Show more ▾ It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. An anti-inflammatory 9-fluoro-glucocorticoid. In 2024, this provider wrote 22 Medicare prescriptions for Dexamethasone, about 68% of the volume of the typical Virginia prescriber of this medication (32.2). Medicare paid an average of $23.99 per fill, versus $15.01 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 22 30-Day Fills standardized to 30-day supplies 289 Days of Medication total across all patients in 2024 | |||
| RevlimidLenalidomide | 20 | $19,239.57 | ▼ Less than typical |
About Revlimid: Lenalidomide is used to treat various types of cancers. Show more ▾ It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. In 2024, this provider wrote 20 Medicare prescriptions for Revlimid, about half the volume of the typical Virginia prescriber of this medication (37.5). Medicare paid an average of $19,239.57 per fill, versus $17,849.64 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 20 30-Day Fills standardized to 30-day supplies 560 Days of Medication total across all patients in 2024 | |||
| CalquenceAcalabrutinib Maleate | 20 | $11,638.74▼ below VA avg | ≈ Typical |
About Calquence: This medication is used to treat certain types of cancer (such as mantle cell lymphoma, small lymphocytic lymphoma - SLL, chronic lymphocytic leukemia - CLL). Show more ▾ Acalabrutinib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors. Inhibits Bruton’s tyrosine kinase; has antineoplastic activity. In 2024, this provider wrote 20 Medicare prescriptions for Calquence, about 88% of the volume of the typical Virginia prescriber of this medication (22.8). Medicare paid an average of $11,638.74 per fill, versus $13,915.10 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 20 30-Day Fills standardized to 30-day supplies 600 Days of Medication total across all patients in 2024 | |||
| Tamoxifen Citrate | 17 | $15.98▼ below VA avg | ▼ Less than typical |
About Tamoxifen Citrate: Tamoxifen is used to treat breast cancer. Show more ▾ It is also used to reduce the chances of breast cancer in high-risk patients. This medication can block the growth of breast cancer. It works by interfering with the effects of estrogen in the breast tissue. One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. In 2024, this provider wrote 17 Medicare prescriptions for Tamoxifen Citrate, about half the volume of the typical Virginia prescriber of this medication (30.2). Medicare paid an average of $15.98 per fill, versus $25.05 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 47 30-Day Fills standardized to 30-day supplies 1,410 Days of Medication total across all patients in 2024 | |||
| Famotidine | 14 | $11.18▼ below VA avg | ▼ Less than typical |
About Famotidine: Famotidine is used to treat ulcers of the stomach and intestines and to prevent intestinal ulcers from coming back after they have healed. Show more ▾ This medication is also used to treat certain stomach and throat (esophagus) problems (such as erosive esophagitis, gastroesophageal reflux disease-GERD, Zollinger-Ellison syndrome). It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as cough that doesn't go away, stomach pain, heartburn, and difficulty swallowing. Famotidine belongs to a class of drugs known as H2 blockers. This medication is also available without a prescription. It is used to prevent and treat heartburn and other symptoms caused by too much acid in the stomach (acid indigestion). If you are taking this medication for self-treatment, it is important to read the manufacturer's package instructions carefully so you know when to consult your doctor or pharmacist. A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion. In 2024, this provider wrote 14 Medicare prescriptions for Famotidine, about a quarter of the volume of the typical Virginia prescriber of this medication (51.4). Medicare paid an average of $11.18 per fill, versus $12.51 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 27 30-Day Fills standardized to 30-day supplies 810 Days of Medication total across all patients in 2024 | |||
| Allopurinol | 14 | $4.03▼ below VA avg | ▼ Less than typical |
About Allopurinol: Allopurinol is used to treat gout and certain types of kidney stones. Show more ▾ It is also used to prevent increased uric acid levels in patients receiving cancer chemotherapy. These patients can have increased uric acid levels due to release of uric acid from the dying cancer cells. Allopurinol works by reducing the amount of uric acid made by the body. Increased uric acid levels can cause gout and kidney problems. A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms. In 2024, this provider wrote 14 Medicare prescriptions for Allopurinol, about a third of the volume of the typical Virginia prescriber of this medication (48.5). Medicare paid an average of $4.03 per fill, versus $8.76 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 33 30-Day Fills standardized to 30-day supplies 990 Days of Medication total across all patients in 2024 | |||
| Ondansetron Hcl | 14 | $14.45▼ below VA avg | ▼ Less than typical |
About Ondansetron Hcl: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. It works by blocking one of the body's natural substances (serotonin) that causes vomiting. A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. In 2024, this provider wrote 14 Medicare prescriptions for Ondansetron Hcl, about half the volume of the typical Virginia prescriber of this medication (30.8). Medicare paid an average of $14.45 per fill, versus $23.07 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 14 30-Day Fills standardized to 30-day supplies 320 Days of Medication total across all patients in 2024 | |||
| TasignaNilotinib Hcl | 13 | $19,536.31 | ≈ Typical |
About Tasigna: Nilotinib is used to treat a certain type of blood cancer (chronic myelogenous leukemia-CML). Show more ▾ It works by slowing or stopping the growth of cancer cells. Antineoplastic agent. In 2024, this provider wrote 13 Medicare prescriptions for Tasigna, about 82% of the volume of the typical Virginia prescriber of this medication (15.9). Medicare paid an average of $19,536.31 per fill, versus $16,626.30 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 366 Days of Medication total across all patients in 2024 | |||
| VenclextaVenetoclax | 12 | $7,787.90▼ below VA avg | ▼ Less than typical |
About Venclexta: This medication is used to treat certain types of cancer (chronic lymphocytic leukemia-CLL, small lymphocytic lymphoma-SLL, acute myeloid leukemia-AML). Show more ▾ Venetoclax is a drug that works by helping to slow or stop the growth of cancer cells. A BCL-2 inhibitor with antineoplastic activity that is used in the treatment of CHRONIC LYMPHOCYTIC LEUKEMIA associated with chromosome 17p deletion. In 2024, this provider wrote 12 Medicare prescriptions for Venclexta, about half the volume of the typical Virginia prescriber of this medication (21.7). Medicare paid an average of $7,787.90 per fill, versus $8,026.31 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 12 30-Day Fills standardized to 30-day supplies 322 Days of Medication total across all patients in 2024 | |||
| Folic Acid | 12 | $5.20▼ below VA avg | ▼ Less than typical |
About Folic Acid: Folic acid is the man-made form of folate. Show more ▾ Folate is a B-vitamin naturally found in some foods. It is needed to form healthy cells, especially red blood cells. Folic acid supplements may come in different forms (such as L-methylfolate, levomefolate, methyltetrahydrofolate). They are used to treat or prevent low folate levels. Low folate levels can lead to certain types of anemia. Conditions that can cause low folate levels include poor diet, pregnancy, alcoholism, liver disease, certain stomach/intestinal problems, kidney dialysis, among others. Women of childbearing age should receive adequate amounts of folic acid either through their diet or supplements to prevent infant spinal cord birth defects. A member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (POACEAE). Folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia. In 2024, this provider wrote 12 Medicare prescriptions for Folic Acid, about half the volume of the typical Virginia prescriber of this medication (22.8). Medicare paid an average of $5.20 per fill, versus $8.35 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 24 30-Day Fills standardized to 30-day supplies 720 Days of Medication total across all patients in 2024 | |||
| AlecensaAlectinib Hcl | 12 | $18,411.12 | ≈ Typical |
About Alecensa: Alectinib is used to treat a certain type of lung cancer. Show more ▾ It works by slowing or stopping the growth of cancer cells. Alectinib belongs to a class of drugs known as tyrosine kinase inhibitors. An ANAPLASTIC LYMPHOMA KINASE (Alk) inhibitor. In 2024, this provider wrote 12 Medicare prescriptions for Alecensa, about 76% of the volume of the typical Virginia prescriber of this medication (15.8). Medicare paid an average of $18,411.12 per fill, versus $17,922.30 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2024 | |||
| Lidocaine-PrilocaineLidocaine/Prilocaine | 11 | $13.19▼ below VA avg | ▼ Less than typical |
About Lidocaine-Prilocaine: This medication contains 2 amide-type local anesthetics, lidocaine and prilocaine. Show more ▾ It is used on normal, unbroken skin or on the outer genital area to prevent pain before certain procedures such as inserting a needle, skin grafts, or skin laser surgery. It works by temporarily numbing the skin and surrounding area. Do not use this product in the ears. If this product alone cannot completely numb the area being treated, it may be used to numb the area before a lidocaine injection is given to provide enough pain relief for certain procedures (such as removal of genital warts). A topical local anesthetic preparation that is composed of a mixture of lidocaine and prilocaine. It is used to provide anesthesia during minor surgery and for the treatment of PREMATURE EJACULATION. In 2024, this provider wrote 11 Medicare prescriptions for Lidocaine-Prilocaine, about half the volume of the typical Virginia prescriber of this medication (23.3). Medicare paid an average of $13.19 per fill, versus $16.07 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 11 30-Day Fills standardized to 30-day supplies 286 Days of Medication total across all patients in 2024 | |||
| Hydrocortisone | 11 | $57.17 | ▼ Less than typical |
About Hydrocortisone: This medication is used to treat a variety of skin conditions (such as insect bites, poison oak/ivy, eczema, dermatitis, allergies, rash, itching of the outer female genitals, anal itching). Show more ▾ Hydrocortisone reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a mild corticosteroid. The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. In 2024, this provider wrote 11 Medicare prescriptions for Hydrocortisone, about a third of the volume of the typical Virginia prescriber of this medication (28.6). Medicare paid an average of $57.17 per fill, versus $16.94 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 15.7 30-Day Fills standardized to 30-day supplies 471 Days of Medication total across all patients in 2024 | |||
| Fentanyl | 11 | $89.27▼ below VA avg | ▼ Less than typical |
About Fentanyl: This medication is used to help relieve severe ongoing pain (such as due to cancer). Show more ▾ Fentanyl belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. Do not use the patch form of fentanyl to relieve pain that is mild or that will go away in a few days. This medication is not for occasional ("as needed") use. A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078) In 2024, this provider wrote 11 Medicare prescriptions for Fentanyl, about a third of the volume of the typical Virginia prescriber of this medication (30.8). Medicare paid an average of $89.27 per fill, versus $121.49 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2024 | |||
| TruqapCapivasertib | 11 | $23,037.36 | – No State Data |
About Truqap: Capivasertib is used with another medication (fulvestrant) to treat breast cancer. Show more ▾ Capivasertib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. In 2024, this provider wrote 11 Medicare prescriptions for Truqap. Medicare paid an average of $23,037.36 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $23,037.36 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 308 Days of Medication total across all patients in 2024 | |||
| Imatinib Mesylate | 11 | $1,623.56 | ▼ Less than typical |
About Imatinib Mesylate: This medication is used to treat certain types of cancer (such as acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases). Show more ▾ It works by slowing or stopping the growth of cancer cells. Imatinib may also be used to treat certain immune system disorders (such as aggressive systemic mastocytosis, hypereosinophilic syndrome). A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors. In 2024, this provider wrote 11 Medicare prescriptions for Imatinib Mesylate, about half the volume of the typical Virginia prescriber of this medication (19.1). Medicare paid an average of $1,623.56 per fill, versus $1,388.27 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for DR. PADMAJA V MALLIDI M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hematology & Oncology prescribing approach at this Roanoke, VA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among VA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
